Michael Recht

7.8k citations

140 papers · 2.6k indexed · h-index 29

Impact in

Hematology top 0.5%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Genetics top 2%
- Virus-based gene therapy research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in ⓘ

Hematology 123
- Hemophilia Treatment and Research 108
- Platelet Disorders and Treatments 32
- Blood Coagulation and Thrombosis Mechanisms 26
Genetics 29
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 14
- Virus-based gene therapy research 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8

Co-authors: Ernest C. Borden (1 shared paper)E. Knight (1 shared paper)David L. Cooper (20 shared papers)Robert Gut (11 shared papers)Kristina M. Haley (9 shared papers)Susan Lattimore (16 shared papers)Michelle Witkop (12 shared papers)Michael Wang (11 shared papers)
Journals: Haemophilia (35 papers)Blood (35 papers)Research and Practice in Thrombosis and Haemostasis (6 papers)Blood Advances (6 papers)Value in Health (5 papers)
Partner nations: United States Italy Germany

In The Last Decade

Michael Recht

132 papers receiving 2.5k citations

Peers

Countries citing papers authored by Michael Recht

Since Specialization

Citations

This map shows the geographic impact of Michael Recht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Recht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Recht more than expected).

Fields of papers citing papers by Michael Recht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Recht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Recht. The network helps show where Michael Recht may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Recht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Recht Line = papers co-authored together Michael Recht links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma The Journal of Immunology ·Michael Recht, Ernest C. Borden, E. Knight	1991	155
2	Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A New England Journal of Medicine ·Lindsey A. George, Paul E. Monahan, M. Elaine Eyster, Spencer K. Sullivan, Margaret V. Ragni, Stacy E. Croteau, John E.J. Rasko, Michael Recht, Benjamin J. Samelson‐Jones, Amy MacDougall, Kristen Jaworski, Robert Noble, Marla Curran, Klaudia Kuranda, Federico Mingozzi, Tiffany Chang, Kathleen Z. Reape, Xavier M. Anguela, Katherine A. High	2021	152
3	Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia Haemophilia ·Gregory J. Gerstner, Mary Lou Damiano, Abdel Rahman El Tom, Christina Worman, Wendy Schultz, Michael Recht, Alison Stopeck	2009	105
4	Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study Haemophilia ·Michelle Witkop, Anne T. Neff, Tyler W. Buckner, Michael Wang, Katharine Batt, Craig M. Kessler, Doris Quon, Lisa Boggio, Michael Recht, Kim Baumann, Robert Gut, David L. Cooper, Christine L. Kempton	2017	99
5	Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B Blood Advances ·Annette von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe	2019	96
6	Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer Blood ·Amit C. Nathwani, Ulrike M. Reiss, Edward G. D. Tuddenham, Pratima Chowdary, Jenny McIntosh, Anne Riddell, Jun Pie, Johnny Mahlangu, Michael Recht, Yu‐Min Shen, Kathleen G. Halka, Michael M. Meagher, Arthur W. Nienhuis, Andrew M. Davidoff, Sarah Mangles, Chris L Morton, Junfang Zhou, Vlad C. Radulescu	2018	94
7	Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach–Merritt phenomenon Pediatric Blood & Cancer ·Yvonne E. Chiu, Beth A. Drolet, Francine Blei, Manuel Carção, Jason Fangusaro, Michael Kelly, Alfons Krol, Sabra Lofgren, Anthony J. Mancini, Denise W. Metry, Michael Recht, Robert A. Silverman, Wynnis L. Tom, Elena Pope	2012	88
8	Reformulated BeneFix^®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B Haemophilia ·Thierry Lambert, Michael Recht, Leonard A. Valentino, Jerry S. Powell, Chandrasekhar Udata, S. T. SULLIVAN, David A. Roth	2007	76
9	Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study Blood Advances ·Beth Boulden Warren, Dianne Thornhill, Jill Stein, Michael Fadell, J. David Ingram, Sharon Funk, Kristi L. Norton, Heidi Lane, Carolyn M. Bennett, Amy L. Dunn, Michael Recht, Amy D. Shapiro, Marilyn J. Manco‐Johnson	2020	75
10	Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII Haemophilia ·Michael Recht, László Nemes, Michał Matysiak, Marilyn J. Manco‐Johnson, Jeanne M. Lusher, Mark P. Smith, P.M. Mannucci, C. R. M. Hay, Thomas C. Abshire, Amanda C. O’Brien, Brooke Hayward, Chandrasekhar Udata, David A. Roth, Steven Arkin	2009	67
11	Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis Blood Reviews ·Bethany Samuelson Bannow, Michael Recht, Claude Négrier, Cédric Hermans, Erik Berntorp, Hermann Eichler, Maria Elisa Mancuso, Robert Klamroth, Jamie O’Hara, Elena Santagostino, Tadashi Matsushita, Craig M. Kessler	2019	66
12	Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy Haemophilia ·Steven R. Lentz, Mudi Misgav, Margareth C. Ozelo, Silva Zupančić Šalek, Dobrila Veljković, Michael Recht, M. Cerqueira, Andreas Tiede, B. Brand, Maria Elisa Mancuso, Stephanie Seremetis, Annika Lindblom, U. Martinowitz	2013	66
13	Overweight and Obesity in Hemophilia American Journal of Preventive Medicine ·Trisha E. Wong, Suvankar Majumdar, Elizabeth Adams, Sarah Bergman, Mary Lou Damiano, Joann Deutsche, Michael Recht	2011	53
14	Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia Value in Health ·Ellis J. Neufeld, Michael Recht, Hernan Sabio, Kapil Saxena, Caitlyn T. Solem, A. Simon Pickard, Robert Gut, David L. Cooper	2012	51
15	The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A Haemophilia ·J. Michael Soucie, Chang-Wen Wang, Abdullah Siddiqi, Roshni Kulkarni, Michael Recht, Barbara A. Konkle	2011	45
16	Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2) Blood ·Rebecca Kruse‐Jarres, Michael U. Callaghan, Stacy E. Croteau, Víctor Jiménez‐Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul G. Solari, Johannes Oldenburg	2017	43
17	The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption Haemophilia ·Michael Recht, Meghan S. Liel, Russell T. Turner, Robert F. Klein, Jason Taylor	2013	43
18	Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study Haemophilia ·Christine L. Kempton, Michael Recht, Anne T. Neff, Michael Wang, Tyler W. Buckner, Amit Soni, Doris Quon, Michelle Witkop, Lisa Boggio, Robert Gut, David L. Cooper	2017	42
19	Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy Blood Advances ·Annette von Drygalski, Esteban Moreno Gómez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Robert Gut, Ricardo E. Dolmetsch, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe	2022	40
20	Assessment of neonatal platelet adhesion, activation, and aggregation Journal of Thrombosis and Haemostasis ·Sandra M. Baker-Groberg, Susan Lattimore, Michael Recht, Owen J. T. McCarty, Kristina M. Haley	2016	39

About Michael Recht

Michael Recht is a scholar working on Hematology, Genetics, Genetics, Internal Medicine and Family Practice, having authored 140 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (108 papers), Platelet Disorders and Treatments (32 papers), Blood Coagulation and Thrombosis Mechanisms (26 papers), Cancer-related gene regulation (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (426 citations), Oncology (400 citations), Genetics (403 citations) and Internal Medicine (28 citations). Michael Recht has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Ernest C. Borden, E. Knight, David L. Cooper, Robert Gut, Kristina M. Haley, Susan Lattimore, Michelle Witkop, Michael Wang, Trisha E. Wong and Christine L. Kempton. Their work appears in journals such as Haemophilia, Blood, Research and Practice in Thrombosis and Haemostasis, Blood Advances and Value in Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact